Comparing Focalin XR vs QuilliChew ER
| Focalin XR (dexmethylphenidate) | QuilliChew ER (methylphenidate) |
|
|---|
| Focalin XR (dexmethylphenidate) | QuilliChew ER (methylphenidate) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Focalin XR is an extended-release capsule that only needs to be taken once daily. It improves the symptoms of ADHD but carries with it a risk of dependence. Prescribed for ADHD. Focalin XR may also... View more |
Prescription only
Prescribed for ADHD. QuilliChew ER may also be used for purposes not listed in this medication guide. |
Related suggestions ADHD (Attention Deficit Hyperactivity Disorder)
Popular comparisons
|
|||||||||||||||
| More about Focalin XR (dexmethylphenidate) | More about QuilliChew ER (methylphenidate) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Focalin XR has an average rating of 6.7 out of 10 from a total of 116 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 24% reported a negative effect. |
QuilliChew ER has an average rating of 6.0 out of 10 from a total of 2 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 50% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Focalin XR side effects |
View all QuilliChew ER side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Focalin XR prices |
View all QuilliChew ER prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other dexmethylphenidate brands include: Focalin | Other methylphenidate brands include: Aptensio XR, Concerta, Cotempla XR-ODT, Daytrana, Jornay PM, Metadate CD, Methylin, Methylin ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA View more | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
3 hours |
4 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 204 drugs are known to interact with Focalin XR:
|
A total of 207 drugs are known to interact with QuilliChew ER:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
May 26, 2005 |
December 04, 2015 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
|||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.